Atypical Teratoid Rhabdoid Tumor drugs in development, 2024

GlobalData tracks 18 drugs in development for Atypical Teratoid Rhabdoid Tumor by 16 companies/universities/institutes. The top development phase for Atypical Teratoid Rhabdoid Tumor is preclinical, with six drugs in that stage.

Public health strategies skip patients with rare diseases, says UK study – Pharmaceutical Technology

The study found eight rare diseases associated with increased risk of Covid-19-related mortality. Credit: imageBROKER/Berit Kessler via Getty Images. Researchers in the UK are calling

February 10, 2025

Preterm birth risk highlighted in Stanford-led study on sleep and activity during pregnancy

Researchers developed series2signal, a novel, state-of-the-art prediction model that used wearable data from pregnant women to predict gestational age as a proxy for the progression of pregnancy

October 2, 2023

4 Key Ways QHINs Will Improve Healthcare Interoperability

John Blair, MD, CEO of MedAlllies Like tales of Bigfoot and UFO sightings, talk of Qualified Health Information Networks (QHINs) has been met around the

January 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.